• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的研究:用于老年分化型甲状腺癌患者的预后列线图模型。

Prognostic nomogram models for elderly patients with differentiated thyroid carcinoma: A population-based study.

机构信息

Department of Breast and Thyroid Surgery, Suining Central Hospital, Suining, Sichuan Province, China.

出版信息

Medicine (Baltimore). 2024 Nov 1;103(44):e40381. doi: 10.1097/MD.0000000000040381.

DOI:10.1097/MD.0000000000040381
PMID:39496024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11537660/
Abstract

This study aimed to develop and validate a prognostic model for elderly patients with differentiated thyroid carcinoma (DTC) based on various demographic and clinical parameters in order to accurately predict patient outcomes. Patients who were diagnosed with DTC and were over 55 years old between 2010 and 2019 were identified from the Surveillance, Epidemiology, and End Results database. The patients were then randomly divided into a training set and a validation set in a 7:3 ratio, and patients from our center were included as an external validation group. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify independent prognostic factors, which were then utilized to develop nomograms for predicting the prognosis. The discriminative ability of the nomograms was evaluated using the concordance index, and the calibration was assessed using calibration plots. The clinical usefulness and benefits of the predictive models were determined through decision curve analysis. The findings of the stepwise Cox regression analysis revealed that several variables, including age, marital status, sex, multifocality, T stage, N stage, and M stage, were significantly associated with overall survival in elderly patients with DTC. Additionally, age, tumor size, multifocality, T stage, N stage, and M stage were identified as the primary determinants of cancer specific survival in elderly patients with DTC. Using these predictors, nomograms were constructed to estimate the probability of overall survival and cancer specific survival. The nomograms demonstrated a high level of predictive accuracy, as evidenced by the concordance index, and the calibration plots indicated that the predicted outcomes were consistent with the actual outcomes. Furthermore, the decision curve analysis demonstrated that the nomograms provided substantial clinical net benefit, indicating their utility in clinical practice.

摘要

本研究旨在基于各种人口统计学和临床参数为老年分化型甲状腺癌 (DTC) 患者开发和验证一种预后模型,以准确预测患者的结局。从监测、流行病学和最终结果数据库中确定了 2010 年至 2019 年间诊断为 DTC 且年龄超过 55 岁的患者。然后,患者被随机分为 7:3 的训练集和验证集,我们中心的患者被纳入外部验证组。进行单变量和多变量 Cox 比例风险回归分析以确定独立的预后因素,然后利用这些因素开发用于预测预后的列线图。通过一致性指数评估列线图的判别能力,并通过校准图评估校准。通过决策曲线分析确定预测模型的临床实用性和获益。逐步 Cox 回归分析的结果表明,几个变量,包括年龄、婚姻状况、性别、多灶性、T 分期、N 分期和 M 分期,与老年 DTC 患者的总生存率显著相关。此外,年龄、肿瘤大小、多灶性、T 分期、N 分期和 M 分期被确定为老年 DTC 患者癌症特异性生存率的主要决定因素。使用这些预测因子,构建了列线图以估计总生存率和癌症特异性生存率的概率。列线图表现出高度的预测准确性,一致性指数证明了这一点,校准图表明预测结果与实际结果一致。此外,决策曲线分析表明,列线图提供了实质性的临床净获益,表明它们在临床实践中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/857b956d6c5a/medi-103-e40381-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/ff2abe873820/medi-103-e40381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/cee1f20c53d1/medi-103-e40381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/b040ae384e97/medi-103-e40381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/b3586b0f226a/medi-103-e40381-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/537e50dbad69/medi-103-e40381-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/857b956d6c5a/medi-103-e40381-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/ff2abe873820/medi-103-e40381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/cee1f20c53d1/medi-103-e40381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/b040ae384e97/medi-103-e40381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/b3586b0f226a/medi-103-e40381-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/537e50dbad69/medi-103-e40381-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e3/11537660/857b956d6c5a/medi-103-e40381-g006.jpg

相似文献

1
Prognostic nomogram models for elderly patients with differentiated thyroid carcinoma: A population-based study.基于人群的研究:用于老年分化型甲状腺癌患者的预后列线图模型。
Medicine (Baltimore). 2024 Nov 1;103(44):e40381. doi: 10.1097/MD.0000000000040381.
2
Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.基于 SEER 数据库分析建立低分化甲状腺癌患者癌症特异性生存的列线图模型并验证
Front Endocrinol (Lausanne). 2022 Sep 13;13:882279. doi: 10.3389/fendo.2022.882279. eCollection 2022.
3
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.
4
Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.基于第八版 AJCC 分期和竞争风险模型的分化型甲状腺癌患者列线图。
JNCI Cancer Spectr. 2021 Apr 22;5(3). doi: 10.1093/jncics/pkab038. eCollection 2021 Jun.
5
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
6
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
7
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database.基于 SEER 数据库构建并验证预测重新定义的间变性甲状腺癌患者总生存的列线图。
Int J Clin Oncol. 2024 Jun;29(6):744-754. doi: 10.1007/s10147-024-02495-2. Epub 2024 Apr 7.
8
Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer: A SEER Database Analysis.未治疗的甲状腺乳头状癌的自然史和预后模型:SEER 数据库分析。
Cancer Control. 2024 Jan-Dec;31:10732748241253956. doi: 10.1177/10732748241253956.
9
Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.基于 SEER 计划的研究:分化型甲状腺癌伴远处转移患者生存列线图的建立与验证。
J Endocrinol Invest. 2024 Jan;47(1):115-129. doi: 10.1007/s40618-023-02129-w. Epub 2023 Jun 9.
10
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.

引用本文的文献

1
Identification of potential biomarkers for hepatocellular carcinoma based on machine learning and bioinformatics analysis.基于机器学习和生物信息学分析的肝细胞癌潜在生物标志物的鉴定
Discov Oncol. 2024 Dec 18;15(1):808. doi: 10.1007/s12672-024-01667-w.

本文引用的文献

1
Establishment and verification of the first prognostic nomograms in locally advanced thyroid cancer based on the analysis of clinical and follow-up information on 2396 patients.基于对2396例患者的临床和随访信息分析,建立并验证首个局部晚期甲状腺癌预后列线图。
Heliyon. 2024 Jan 30;10(3):e24798. doi: 10.1016/j.heliyon.2024.e24798. eCollection 2024 Feb 15.
2
Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.基于 SEER 数据库分析建立低分化甲状腺癌患者癌症特异性生存的列线图模型并验证
Front Endocrinol (Lausanne). 2022 Sep 13;13:882279. doi: 10.3389/fendo.2022.882279. eCollection 2022.
3
Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience.
桥本甲状腺炎与分化型甲状腺癌之间的关联:单中心经验
Front Oncol. 2022 Jul 28;12:959595. doi: 10.3389/fonc.2022.959595. eCollection 2022.
4
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.甲状腺癌临床实践指南(NCCN 指南)2022 年第 2 版。
J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040.
5
Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.肿瘤分期与美国甲状腺协会风险分级在甲状腺癌中的预后价值。
Laryngoscope. 2023 Jan;133(1):205-211. doi: 10.1002/lary.30252. Epub 2022 Jun 18.
6
Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival.老年甲状腺分化癌:年龄对无病生存和总体生存的影响。
Endocrine. 2022 Jun;77(1):121-133. doi: 10.1007/s12020-022-03059-y. Epub 2022 May 18.
7
T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.T 细胞耗竭与甲状腺乳头状癌的风险相关,并且可以作为一种预测性和敏感性的生物标志物用于诊断。
Diagn Pathol. 2021 Aug 31;16(1):84. doi: 10.1186/s13000-021-01139-7.
8
Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system.建立和验证预测分化型甲状腺癌患者生存概率的列线图模型:与第八版 AJCC 癌症分期系统的比较。
Endocrine. 2021 Oct;74(1):108-119. doi: 10.1007/s12020-021-02717-x. Epub 2021 Apr 6.
9
Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.甲状腺癌过度诊断和过度治疗:厄瓜多尔一家甲状腺癌转诊中心的横断面研究。
BMC Cancer. 2021 Jan 8;21(1):42. doi: 10.1186/s12885-020-07735-y.
10
Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.甲状腺微小乳头状癌主动监测是可行且安全的:来自意大利单一中心的经验。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e172-80. doi: 10.1210/clinem/dgz113.